EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
WO2016023511A1
(en)
*
|
2014-08-15 |
2016-02-18 |
正大天晴药业集团股份有限公司 |
Pyrrolopyrimidine compounds used as tlr7 agonist
|
ES2753777T3
(en)
|
2015-05-08 |
2020-04-14 |
Hoffmann La Roche |
Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of viral infections
|
MA44334A
(en)
|
2015-10-29 |
2018-09-05 |
Novartis Ag |
ANTIBODY CONJUGATES INCLUDING A TOLL-TYPE RECEPTOR AGONIST
|
EA035116B1
(en)
*
|
2015-11-05 |
2020-04-29 |
Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. |
7-(thiazol-5-yl)pyrrolopyrimidine as tlr7 receptor agonist
|
CN107043380A
(en)
*
|
2016-02-05 |
2017-08-15 |
正大天晴药业集团股份有限公司 |
A kind of maleate of TLR7 activators, its crystal formation C, crystal formation D, crystal formation E, preparation method and purposes
|
CN107043378A
(en)
*
|
2016-02-05 |
2017-08-15 |
正大天晴药业集团股份有限公司 |
A kind of Preparation Method And Their Intermediate of pyrrolo- [3,2-d] pyrimidines
|
CN107043377A
(en)
|
2016-02-05 |
2017-08-15 |
正大天晴药业集团股份有限公司 |
A kind of trifluoroacetate of TLR7 activators, crystal formation B and preparation method thereof, pharmaceutical composition and purposes
|
CN107043379A
(en)
|
2016-02-05 |
2017-08-15 |
正大天晴药业集团股份有限公司 |
A kind of crystal formation A, its preparation method and the medical usage of TLR7 activators
|
AU2017273857B2
(en)
|
2016-06-01 |
2021-08-19 |
Athira Pharma, Inc. |
Compounds
|
JOP20190024A1
(en)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
Substituted pyrrolizine compounds and uses thereof
|
SG11201901633WA
(en)
|
2016-08-29 |
2019-03-28 |
Hoffmann La Roche |
7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
|
PE20190732A1
(en)
|
2016-09-09 |
2019-05-23 |
Novartis Ag |
COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL RECEIVERS TYPE TYPE
|
MX2019002678A
(en)
|
2016-09-13 |
2019-05-20 |
Hoffmann La Roche |
Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor.
|
JP6811857B2
(en)
|
2016-10-14 |
2021-01-13 |
プレシジョン バイオサイエンシズ,インク. |
Genetically engineered meganuclease specific for the recognition sequence of the hepatitis B virus genome
|
WO2018078149A1
(en)
*
|
2016-10-31 |
2018-05-03 |
F. Hoffmann-La Roche Ag |
Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
WO2018086593A1
(en)
|
2016-11-11 |
2018-05-17 |
礼沃(上海)医药科技有限公司 |
Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use
|
RU2748833C2
(en)
*
|
2016-11-28 |
2021-05-31 |
Цзянсу Хэнжуй Медсин Ко., Лтд. |
Pyrazolo-heteroaryl derivative, method for its preparation and medical use
|
US11111249B2
(en)
|
2017-05-18 |
2021-09-07 |
Jiangsu Hengrui Medicine Co., Ltd. |
Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereof
|
US10508115B2
(en)
|
2017-08-16 |
2019-12-17 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor
|
US10457681B2
(en)
|
2017-08-16 |
2019-10-29 |
Bristol_Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
|
US10487084B2
(en)
|
2017-08-16 |
2019-11-26 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor
|
US10472361B2
(en)
|
2017-08-16 |
2019-11-12 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor
|
US10494370B2
(en)
|
2017-08-16 |
2019-12-03 |
Bristol-Myers Squibb Company |
Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor
|
WO2019099336A1
(en)
|
2017-11-14 |
2019-05-23 |
Bristol-Myers Squibb Company |
Substituted indole compounds
|
ES2960411T3
(en)
|
2017-12-18 |
2024-03-04 |
Bristol Myers Squibb Co |
4-azaindole compounds
|
EA202091474A1
(en)
|
2017-12-19 |
2020-11-18 |
Бристол-Маерс Сквибб Компани |
SUBSTITUTED INDOLE COMPOUNDS USED AS TLR INHIBITORS
|
KR20200101398A
(en)
|
2017-12-19 |
2020-08-27 |
브리스톨-마이어스 스큅 컴퍼니 |
Amide substituted indole compounds useful as TLR inhibitors
|
EA202091508A1
(en)
*
|
2017-12-19 |
2020-09-14 |
Бристол-Маерс Сквибб Компани |
6-AZAINDOL CONNECTIONS
|
JP7037667B2
(en)
|
2017-12-20 |
2022-03-16 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
3'3'cyclic dinucleotide with phosphonate binding that activates the STING adapter protein
|
AU2018392212B9
(en)
|
2017-12-20 |
2021-03-18 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein
|
MX2020006014A
(en)
|
2017-12-20 |
2020-08-17 |
Bristol Myers Squibb Co |
Diazaindole compounds.
|
EP3728188B1
(en)
|
2017-12-20 |
2023-10-11 |
Bristol-Myers Squibb Company |
Aryl and heteroaryl substituted indole compounds
|
EP3728218B1
(en)
|
2017-12-20 |
2021-12-01 |
Bristol-Myers Squibb Company |
Amino indole compounds useful as tlr inhibitors
|
JP7328977B2
(en)
|
2018-02-12 |
2023-08-17 |
エフ. ホフマン-ラ ロシュ アーゲー |
Novel sulfone compounds and derivatives for the treatment and prevention of viral infections
|
WO2019165374A1
(en)
|
2018-02-26 |
2019-08-29 |
Gilead Sciences, Inc. |
Substituted pyrrolizine compounds as hbv replication inhibitors
|
US10870691B2
(en)
|
2018-04-05 |
2020-12-22 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis B virus protein X
|
JP7296398B2
(en)
|
2018-04-06 |
2023-06-22 |
インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー エーエスシーアール,ヴイ.ヴイ.アイ. |
3'3'-cyclic dinucleotide
|
TWI818007B
(en)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-cyclic dinucleotides
|
TW202005654A
(en)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2'2'-cyclic dinucleotides
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
WO2019209811A1
(en)
|
2018-04-24 |
2019-10-31 |
Bristol-Myers Squibb Company |
Macrocyclic toll-like receptor 7 (tlr7) agonists
|
TW202014193A
(en)
|
2018-05-03 |
2020-04-16 |
捷克科學院有機化學與生物化學研究所 |
2’3’-cyclic dinucleotides comprising carbocyclic nucleotide
|
EP3816166A4
(en)
*
|
2018-05-25 |
2022-04-06 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Tlr7 agonist and pharmaceutical combination thereof for treating lung cancer
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
US11554120B2
(en)
|
2018-08-03 |
2023-01-17 |
Bristol-Myers Squibb Company |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor
|
CN112839947B
(en)
*
|
2018-10-12 |
2023-01-24 |
正大天晴药业集团股份有限公司 |
TLR7 agonist for treating colorectal cancer and pharmaceutical composition thereof
|
BR112021008255A2
(en)
|
2018-10-31 |
2021-08-03 |
Gilead Sciences, Inc. |
substituted 6-azabenzimidazole compounds as hpk1 inhibitors
|
AU2019373221B2
(en)
|
2018-10-31 |
2022-05-26 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds having HPK1 inhibitory activity
|
WO2020162705A1
(en)
|
2019-02-08 |
2020-08-13 |
성균관대학교산학협력단 |
Toll-like receptor 7 or 8 agonist-cholesterol complex, and use of same
|
CN113543851A
(en)
|
2019-03-07 |
2021-10-22 |
捷克共和国有机化学与生物化学研究所 |
2'3' -cyclic dinucleotides and their prodrugs
|
US11766447B2
(en)
|
2019-03-07 |
2023-09-26 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3′3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
EP3935066A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
TW202102220A
(en)
*
|
2019-03-15 |
2021-01-16 |
愛爾蘭商健生科學愛爾蘭無限公司 |
Toll-like receptor agonist dosing regimen
|
TWI751516B
(en)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
Solid forms of a toll-like receptor modulator
|
TW202212339A
(en)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
Solid forms of a toll-like receptor modulator
|
CN113543788B
(en)
|
2019-04-23 |
2023-12-19 |
正大天晴药业集团股份有限公司 |
Solid pharmaceutical composition of TLR7 agonist
|
EP3972695A1
(en)
|
2019-05-23 |
2022-03-30 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
EP4008720A4
(en)
|
2019-08-02 |
2023-08-02 |
BeiGene, Ltd. |
Imidazo[2,1-f][1,2,4]triazin-4-amine derivative used as tlr8 agonist
|
US20220296619A1
(en)
|
2019-08-19 |
2022-09-22 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
AU2020355873A1
(en)
*
|
2019-09-29 |
2022-04-28 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Drug combination containing TLR7 agonist
|
CR20220129A
(en)
|
2019-09-30 |
2022-05-06 |
Gilead Sciences Inc |
Hbv vaccines and methods treating hbv
|
EP4069729A1
(en)
|
2019-12-06 |
2022-10-12 |
Precision BioSciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
EP4097104A1
(en)
|
2020-01-27 |
2022-12-07 |
Bristol-Myers Squibb Company |
1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists
|
EP4097101A1
(en)
|
2020-01-27 |
2022-12-07 |
Bristol-Myers Squibb Company |
1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists
|
WO2021154667A1
(en)
|
2020-01-27 |
2021-08-05 |
Bristol-Myers Squibb Company |
C3-SUBSTITUTED 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
|
CN115279765A
(en)
|
2020-01-27 |
2022-11-01 |
百时美施贵宝公司 |
1H-pyrazolo [4,3-d ] pyrimidine compounds as Toll-like receptor 7 (TLR 7) agonists
|
KR20220132593A
(en)
|
2020-01-27 |
2022-09-30 |
브리스톨-마이어스 스큅 컴퍼니 |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists
|
WO2021154664A1
(en)
|
2020-01-27 |
2021-08-05 |
Bristol-Myers Squibb Company |
1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS
|
CN115643805A
(en)
|
2020-01-27 |
2023-01-24 |
百时美施贵宝公司 |
1H-pyrazolo [4,3-d ] pyrimidine compounds as Toll-like receptor 7 (TLR 7) agonists
|
KR20220132601A
(en)
|
2020-01-27 |
2022-09-30 |
브리스톨-마이어스 스큅 컴퍼니 |
1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists
|
CN115210236A
(en)
|
2020-01-27 |
2022-10-18 |
百时美施贵宝公司 |
1H-pyrazolo [4,3-d ] pyrimidine compounds as Toll-like receptor 7 (TLR 7) agonists
|
CA3170551A1
(en)
|
2020-03-02 |
2021-09-10 |
Yong Taik Lim |
Live-pathogen-mimetic nanoparticles based on pathogen cell wall skeleton, and production method thereof
|
AU2021237718B2
(en)
|
2020-03-20 |
2023-09-21 |
Gilead Sciences, Inc. |
Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same
|
AU2021282596A1
(en)
|
2020-06-05 |
2023-01-19 |
Kinnate Biopharma Inc. |
Inhibitors of fibroblast growth factor receptor kinases
|
WO2022031021A1
(en)
|
2020-08-04 |
2022-02-10 |
성균관대학교산학협력단 |
Mrna vaccine comprising adjuvant capable of kinetic control
|
JP2023536945A
(en)
|
2020-08-04 |
2023-08-30 |
プロジェニア インコーポレイテッド |
Kinetic Adjuvant Ensemble
|
EP4194010A1
(en)
|
2020-08-04 |
2023-06-14 |
Progeneer Inc. |
Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
|
CN114805392A
(en)
*
|
2021-01-20 |
2022-07-29 |
上海维申医药有限公司 |
Macrocyclic TLR7 agonist, preparation method thereof, pharmaceutical composition and application thereof
|
CN117083083A
(en)
*
|
2021-03-29 |
2023-11-17 |
正大天晴药业集团股份有限公司 |
Pharmaceutical combination of Toll-like receptor 7 agonist and anti-PD-L1 antibody
|
AU2022274607A1
(en)
|
2021-05-13 |
2023-11-16 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
US20230060354A1
(en)
|
2021-06-23 |
2023-03-02 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
CA3220923A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
KR20240005901A
(en)
|
2021-06-23 |
2024-01-12 |
길리애드 사이언시즈, 인코포레이티드 |
Diacylglycerol Kinase Modulating Compounds
|
CN117377671A
(en)
|
2021-06-23 |
2024-01-09 |
吉利德科学公司 |
Diacylglycerol kinase modulating compounds
|
CN114409654A
(en)
*
|
2021-12-30 |
2022-04-29 |
安徽普利药业有限公司 |
Intermediate synthesis method of BTK inhibitor
|